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Genome-wide association studies (GWAS) of multiple populations with distinctive genetic and lifestyle
backgrounds are crucial to the understanding of Type 2 Diabetes Mellitus (T2DM) pathophysiology. We
report a GWAS on the genetic basis of T2DM in a 3,286 Lebanese participants. More than 5,000,000 SNPs
were directly genotyped or imputed using the 1000 Genomes Project reference panels. We identify
genome-wide significant variants in two loci CDKAL1 and TCF7L2, independent of sex, age and BMI, with
leading variants rs7766070 (OR 5 1.39, P 5 4.77 3 1029) and rs34872471 (OR 5 1.35, P 5 1.01 3 1028)
respectively. The current study is the first GWAS to find genomic regions implicated in T2DM in the
Lebanese population. The results support a central role of CDKAL1 and TCF7L2 in T2DM susceptibility in
Southwest Asian populations and provide a plausible component for understanding molecular mechanisms
involved in the disease.
T
ype 2 diabetes mellitus (T2DM) is a chronic metabolic disease with a complex pathogenesis defined by
genetic predisposition and environmental factors1. In Lebanon, T2DM was evaluated on 8,050 Lebanese
cases in 1990. Its prevalence and incidence, similar to the international averages, were 5.0% and 1.5 to 1.7%
respectively2. In 1992, a study on 436 cases from all over the Lebanese territory gave prevalence of 7 to 8% for
T2DM and 10 to 11% for impaired glucose tolerance3. In 2005, a study on 3,000 exclusively Lebanese individuals
from Greater Beirut showed a prevalence of 11.3% which increased with older age4. The combined prevalence of
previously and newly diagnosed T2DM was 15.8%. At that time, in the U.S., 6.3% of the population had T2DM:
4.5% diagnosed and 1.8% undiagnosed according to the 2004 National Diabetes Fact Sheet. These results suggest
that the prevalence of T2DM in Greater Beirut is relatively high and is increasing among the Lebanese population.
Furthermore, according to the latest figures in the American National Diabetes Statistics Report, 29.1 million
children and adults in the United States have diabetes, and 86 million people have prediabetes5. The pathogenesis
of T2DM is closely associated with a positive family history, male gender, age over 45 years, overweight, hyper-
tension, and abnormal lipid levels. In addition, the genetic contribution to T2DM is well recognized with a total of
91 established associated susceptibility loci6–17. The common variants in the reported loci however account for only
a small proportion of the heritability of T2DM and the functional role of most of these variants remains far from
clear. It is possible that a large number of highly-penetrant but rare T2DM susceptibility genetic variants remain to
be identified. Additional genome-wide explorations including whole genome and exome sequencing in well-
established groups of patients and controls may unravel these additional important genetic disease contributors
which will undoubtedly help us understand the complex mechanisms involved in the development of T2DM.
The prevalence of T2DM is distinctly variable across populations and this variability adds to the disease
complexity. This variability could be due to differences in lifestyle factors such as dietary habits, as well as
behavioral patterns among populations. Multiple established T2DM susceptibility genetic loci have been iden-
tified from previous Genome Wide Association Studies (GWAS) in populations of European and Asian ethni-
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variants in ethnically different populations and to identify novel
predisposing genetic factors that may be stronger in their association
than in previously studied populations.
To identify T2DM susceptibility loci in the Lebanese population,
we performed a GWAS of more than 5,000,000 SNPs, which were
directly genotyped or imputed using the 1000 Genomes Project ref-
erence panels. Our study enrolled 1,388 patients and 1,902 non-
diabetic subjects with detailed cross-sectional demographic and
clinical information. Previously, targeted T2DM susceptibility SNP
replication studies have been conducted in the Lebanese population.
However, this study seeks to establish a baseline association for
T2DM in the Lebanese population and thus it is the first genome-
wide scan to find genomic regions implicated in T2DM. We also
make use of recent reference data from the 1000 Genomes Project,
which was previously shown to identify novel and refined associa-
tions for type 2 diabetes mellitus20,21.
Results
The study population has a mean age of 62.9 (611.1) (Table 1). The
healthy control group has a mean age of 62.40 (611.82), compared to
63.62 6 (9.98) for the T2DM patients. Sixty-three percent of the
individuals were males with 40.05 percent suffering from T2DM.
The mean BMI was of 28.1 (64.6) according to standard measures.
52 samples that failed genotype call rate (,95%)27 and that showed
relatedness (kinship coefficient range . 0.0442)28, were removed.
Imputation. 37995922 sites were imputed. The final set included
5891794 SNPs kept after QC (MAF . 0.05, AIMs removal). The
accuracy of the genotype imputation depends on the array SNP
coverage and the similarity of haplotypes between the study
dataset and the reference panels. The Lebanese population was
previously shown to be genetically very close to Europeans29 that
are well represented in the 1000 Genomes Project references. This
resulted in high imputation accuracy as shown by Impute2 certainty
metric (Figure 1). Figure 1 shows biased imputation confidence
depending on chip with the HumanOmniExpress (,700,000
SNPs) having better imputation accuracy compared to the Quad
BeadChips (,550,000 SNPs). However, leading principal compo-
nents reveals no bias regarding population coverage or stratifi-
cation between chips (FigureS1).
Association with T2DM. To map genetic loci associated with
T2DM, genotyped and imputed data in 3,286 Lebanese individuals
Table 1 | Distribution in the surveyed population of age, gender, BMI, and coronary artery disease by T2DM diagnostic status
Healthy controls T2DM patients Total
Sample size 1,902 1,384 3,286
Age (SD) 62.40 (11.82) 63.62 (9.98) 62.92 (11.1)
Gender (%)
Female 597 (54) 510 (46) 1107
Male 1305 (60) 874 (40) 2179
BMI (SD) 28.07 (4.54) 28.21 (4.74) 28.13 (4.63)
Coronary artery disease (%) 1300 (56) 1022 (44) 2,322
Figure 1 | Imputation accuracy. Per-sample imputation confidence scores between true genotypes and genotypes predicted by imputation, averaged over
imputation chunks. Accuracy increases with increased array SNP coverage.
www.nature.com/scientificreports
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were tested for association with the disease (Figure 2). We identify
variations located on chromosomes 4, 6, 9, 10, 12, and 18 that show
trends of association with T2DM reaching P , 1025 under an
additive model (Supplementary Table 1). Seven variants located in
CDKAL1 (cyclin-dependent kinase 5 regulatory subunit associated
protein 1-like 1) reached genome-wide significance (P , 5 3 1028)
with lead signal rs7766070 (OR 5 1.38, P 5 9.37 3 1029) (Figure 3,
Table 2).
Adjustment for sex, age, and BMI (Table 2) identified 16 addi-
tional genome-wide significant variants in CDKAL1 and TCF7L2
(Transcription factor 7-like 2) and showed that association of these
two loci with T2DM appear to be independent from age and BMI.
These variants are also added to Table S1 along with imputation
scores.
The genomic control inflation factor (l) which compares observed
association statistics against the expected distribution, was 1.073
suggesting possible but marginal over-dispersion of the association
statistics (Figure 4)30.
SNPs of interest that showed trend of association but did not reach
genome-wide significance were 12 variants on chromosome 9
(Supplementary Table 1), overlapping a region with microRNA
3910-1 and 3910-2 downstream the gene ROR2 (receptor tyrosine
kinase-like orphan receptor 2).
Three of the SNPs, rs7766070, rs9368222, and rs34872471, iden-
tified in Table 2 were significant in DIAGRAM consortium6,7,9–11,15,17.
One other, rs1044083315, was identified but not genome wide signifi-
cant (Table S2), but which may be of particular interest in Middle
Eastern populations31. Table S2 lists DIAGRAM consortium study
SNPs along with comparisons with our results and imputation con-
fidence scores.
Discussion
T2DM global prevalence has been steadily increasing over the past 50
years and is today considered a major international health concern.
In addition to environmental factors such as diet and lifestyle, genetic
susceptibility appears to have substantial role in the etiology of
T2DM. Furthermore, T2DM risk alleles show significant disparity
in frequencies across worldwide populations. Studies analyzing dis-
tribution patterns of genetic diseases found that T2DM risk alleles
demonstrated the most extreme differentiation32, with population
frequencies decreasing from Sub-Saharan Africa, and through
Europe to East Asia32,33.
The current work contributes to the ongoing worldwide effort to
identify the genetic factors that affect the risk of T2DM. We provide
analysis in a novel population that is highly admixed with ancestral
components from the Middle East, Europe, Central Asia, and
sub-Saharan Africa29. The risk alleles identified in the Lebanese
population could assist in understanding the disparity in T2DM
prevalence across worldwide populations.
We report the first genome-wide scan for genetic susceptibility to
T2DM in Lebanese subjects. We demonstrate strong association of
T2DM with CDKAL1 and TCF7L2 genes previously shown to pre-
dispose to this condition15,18,19,24,26,34–37. A large number of genetic
variants have recently been identified to be associated with T2DM
in GWASs in Europeans6,10,15,17,19,25. The elucidation of the genetic
mechanisms responsible for the heterogeneous condition of T2DM
in different ethnicities may give important contributions to better
understand the complexity of this disease. While some associations
are consistent across different ethnic groups38,39, some, like the
TCF7L2 variants, have been found to be heterogeneous6,25. Our study
confirmed genome-wide association of 23 different variants across
the CDKAL1 and TCF7L2 genes previously reported to play a role in
T2DM in different populations23,40,41. This association remained sig-
nificant after adjustment for sex, age, and BMI, suggesting that these
risk factors are not likely to be major contributors to the observed
association.
After adjusting for age and BMI, most variants in CDKAL1 and
TCF7L2 showed stronger association to T2DM, indicating that these
genes confer susceptibility to T2DM independently from the classical
clinical risks. Functional studies of these two genes show their
implication in down-regulating blood glucose level. CDKAL1
encodes a 65 kD protein of unknown function expressed in pancre-
atic islet and skeletal muscle26. CDKAL1 shows homology with CDK5
regulatory subunit associated protein 1 (CDK5RAP1), an inhibitor of
CDK5 activation. CDK5 plays a role in the regulation of pancreatic
beta cell function by down-regulating insulin expression42,43. The
TCL7L2 gene product is a high mobility group (HMG) box-contain-
ing transcription factor implicated in blood glucose homeostasis.
TCL7L2 acts through regulation of proglucagon through repression
of the proglucagon gene in enteroendocrine cells via the Wnt signal-
ing pathway44.
T2DM is a socio-economic burden in Lebanon and genetic studies
aim at posing important public health questions in regard to strat-
egies for diagnosis, treatment, and prevention of the disease. Previous
replication studies examining a total of 29 SNPs in the Lebanese
Figure 2 | Manhattan plot. Plot shows results of T2DM GWA analysis assuming additive impact in 3286 Lebanese using .5,000,000 genotyped or
imputed SNPs. The Y-axis corresponds to the significance of the association (2log10 p-values). The X-axis represents the physical location of the variant
colored by chromosome.
www.nature.com/scientificreports
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Figure 3 | Regional association plots for the TCF7L2 (A) and CDKAL1 (B) genes. Each regional plot shows the chromosomal position (hg 19) of SNPs in
the specific region against 2log10 p values estimated assuming additive impact. The SNP with the highest association signal at each locus is shown as a
purple star; the other SNPs are colored according to the extent of LD with that SNP. Estimated recombination rates from the 1000 Genomes Project
European population (release March 2012) are shown as light blue lines.
www.nature.com/scientificreports
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population have identified variants associated with T2DM in
COL8A1, KCNQ1, ALX4, HNF145 (n 5 2071), CDKAL150 (n 5
1422), and TCF7L246,47 (n 5 1610).
Our genome-wide analysis of more than 5,000,000 SNPs in the
largest T2DM study to date in the region has only identified varia-
tions in the CDKAL1 and TCF7L2 genes to be genome wide signifi-
cantly associated with the disease.
Lebanon represents a Levantine region with higher European
affinity than other parts of the Middle East48, and therefore poten-
tially fills in the map between SNPs identified in European popula-
tions contrasted with other Middle Eastern populations. Further,
since T2DM is an emerging issue within the Middle East, these
populations may differentially highlight some variants distinct from
other regions. Even accepting relatively low power compared to that
available in meta-studies, the moderately small number of replicated
GWS significant SNPs in our study is less than expected, especially
given the affinity of Lebanon with other European populations48.
Our results contribute to ongoing efforts to identify and confirm
risk alleles associated with T2DM. Mapping disease alleles in differ-
ent populations can provide important perspectives in disease dia-
gnosis and steer functional studies to provide better understanding of
the pathogenesis of T2DM.
Methods
Study Participants. The Lebanese study participants were all of Lebanese origin and
were recruited to this study in three phases. A first recruitment campaign, conducted
with the collaboration of the Lebanese University Medical Center, led to the
recruitment of 506 subjects from the suburbs of Beirut, the capital of Lebanon. In a
second campaign conducted in North Lebanon, 492 subjects were successfully
recruited. The 2,292 remaining participants were recruited as part of the Functional
Genomic Diagnostic Tools for Coronary Artery Disease project initiative
(FGENTCARD) from the Rafic Hariri University Hospital, and the ‘‘Centre
Hospitalier du Nord’’ in Lebanon49,50. Research and methods were carried out in
compliance with the Helsinki Declaration and with the approval of the LAU
institutional review board and local ethics committees on human research (Reference
number SMPZ08072010-4). All participants signed an informed consent and data
and blood samples were obtained from each individual. By taking part in the two
recruitment campaigns, participants (1) answered a detailed questionnaire, (2) gave a
blood sample for DNA analysis and (3) gave a blood sample for HbA1C, fasting blood
glucose (FBS), and lipid profile measures after 12 hours fasting. For the remaining
FGENTCARD 2,292 participants, a detailed questionnaire was duly filled, a blood
sample was obtained for DNA and metabolites analysis and annotations were coded
from medical charts for data such as laboratory tests, prescribed medications, and
presence of clinical conditions. Table 1 describes clinical and demographic
Figure 4 | Quantile-Quantile plot of the GWAS results. Plot compares observed 2log10 p values of the tested SNPs on the vertical axis to expected
2log10 p values under the null hypothesis on the horizontal axis. The genomic control ratio was 1.073, indicating the lack of strong effect of systematic
error such as population stratification.
www.nature.com/scientificreports
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characteristics of the study participants49. Previously reported51 analysis of these
subjects showed association with recruitment for questionnaire variables, such as
‘‘exercise level,’’ ‘‘smoking usage’’. However, blood panel associations showed very
consistent odds ratios for T2DM and coronary artery disease risk independently of
recruitment.
Selection of Patients and Controls. For the 998 participants selected through the two
recruitment campaigns, an HbA1C of 48 mmol/mol (6.5%) was used as the cut-off
point for diagnosing T2DM in line with the World Health Organization definition of
type 2 diabetes mellitus diagnosis52. For the 2,292 participants from the
FGENTCARD project, T2DM was diagnosed by an ascertained physician supported
by subjects HbA1C levels and or their two-hour plasma glucose concentration after
an oral glucose tolerance test as documented in their medical records. For the control
dataset, 85.23% of the participants were $50 years old and have no history of T2DM.
Body mass index (BMI) was calculated according to standard measurements.
Selection criteria for DNA analysis were based on the complete availability of the
genotyping data and the T2DM-relevant characteristics, resulting in the selection of
3,286 subjects.
Genotyping and imputation. DNA was extracted using a standard phenol-
chloroform extraction procedure. Samples were genotyped using Illumina
HumanOmniExpress-12V1-1 Multi-use (623 controls, 839 cases, ,700,000 SNPs)
and Illumina Human610-660W Quad BeadChips (1279 controls, 545 cases,
,550,000 SNPs). Plink27 was used for data management and quality control keeping
3,286 samples with call rate $95%, SNPs call rate $98%, Hardy-Weinberg p . 1026,
MAF $ 1%. Genotype data was converted to NCBI genome build 37 using LiftOver
(http://genome.ucsc.edu/cgi-bin/hgLiftOver). Chromosomes were phased with
SHAPEIT53 using the 1000 Genomes Phase I haplotypes54 provided on the IMPUTE2
website (1000 Genomes Phase I integrated haplotypes (produced using SHAPEIT2),
September 2013) based on sequence data for 1,092 TGP samples from release
20110521. IMPUTE255 was employed to impute genotypes in blocks of ,5 Mb using
all populations in the 1000 Genomes Phase I data. Accuracy of imputation was
measured using IMPUTE2’s information metric ‘‘info’’.
Statistical analysis. GWAS can be confounded by population stratification. The most
common approach to correct for population stratification is to include the principal
components from the PCA as covariates. However, there is no solid method to
determine how many components to include and selection is usually subjective with
inconclusive results. Correction for stratification becomes even more complicated in
populations like the Lebanese where genetic structure is recent and not driven by the
usual factors of distance and geography29. Furthermore, previous studies have shown
that historical migrations to Lebanon have potentially created disease-associated
population structures that are similar to those in the source populations22,56. In this
study, we use insights from our previous studies on population stratifications in the
Lebanese to avoid type 1 errors in the GWAS.
We apply a method that uses available 1000 Genomes Project reference panels to
impute a resolved ancestry dataset29 as well as the current T2DM cohort to the same
SNP coverage resolution. We next use two model-based clustering methods to un-
ambiguously classify subjects into groups (Figure 5):
. 1- mclust (http://www.stat.washington.edu/mclust/) uses model-based hierarch-
ical clustering and Bayesian Information Criterion to classify samples into related
groups.
. 2- ADMIXTURE57 assigns individuals in a model-based manner into ancestral
populations using maximum likelihood estimates.
The two methods identified similar population structures and assigned samples
into three ancestral groups (Figure 5) similar to previous ancestry reports on the
Lebanese29. We next proceed by extracting 192,310 ancestry informative markers
(AIMs) between the groups and exclude it from the GWA analysis. We have also
tested our method by using the identified ancestry groups as covariates in the GWAS
and obtained identical results.
Association tests were performed using SNPTEST v2.458, employing frequentist
association tests and taking into account uncertainty in imputed genotypes (calling
threshold 0.9). At each SNP, an additive, dominant, or recessive model was tested
versus a model of no association. Association tests were also conditioned on age, sex,
and BMI to test for a genetic effect over and above that explained by these covariates.
Chip type and enrollment were also both included in a separate analysis; results
showed correlated but no genome-wide significant SNPs. Further, a PCA painted by
chip type (Figure S1) shows no significant bias. LocusZoom59 was used to plot
regional association results from the genome-wide association scans.
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